Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This study assessed the efficacy of fingolimod in patients with short duration relapsing-remitting multiple sclerosis who had not been previously treated with disease-modifying therapies (DMTs), versus patients with the same disease duration who had previously received first-line DMTs.
Epistemonikos ID: 1cb8647aa887b46d92a8e1167cea47713fdf45f5
First added on: May 10, 2024